AlphaQuest LLC Has $150,000 Position in Integer Holdings Corporation $ITGR

AlphaQuest LLC lessened its holdings in shares of Integer Holdings Corporation (NYSE:ITGR) by 90.2% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,451 shares of the medical equipment provider’s stock after selling 13,294 shares during the quarter. AlphaQuest LLC’s holdings in Integer were worth $150,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Salomon & Ludwin LLC bought a new position in shares of Integer during the 3rd quarter valued at $26,000. Global Retirement Partners LLC increased its position in Integer by 293.8% during the third quarter. Global Retirement Partners LLC now owns 319 shares of the medical equipment provider’s stock worth $33,000 after buying an additional 238 shares during the last quarter. CWM LLC raised its holdings in Integer by 46.1% during the second quarter. CWM LLC now owns 355 shares of the medical equipment provider’s stock valued at $44,000 after buying an additional 112 shares in the last quarter. MAI Capital Management lifted its position in shares of Integer by 220.9% in the second quarter. MAI Capital Management now owns 369 shares of the medical equipment provider’s stock worth $45,000 after buying an additional 254 shares during the last quarter. Finally, EverSource Wealth Advisors LLC boosted its stake in shares of Integer by 210.5% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 534 shares of the medical equipment provider’s stock worth $66,000 after acquiring an additional 362 shares in the last quarter. 99.29% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research analysts recently weighed in on ITGR shares. Weiss Ratings reissued a “sell (d+)” rating on shares of Integer in a research note on Monday, December 29th. Truist Financial lifted their price target on shares of Integer from $86.00 to $95.00 and gave the company a “buy” rating in a research report on Thursday, December 18th. Piper Sandler reduced their price objective on shares of Integer from $155.00 to $82.00 and set an “overweight” rating for the company in a research note on Friday, October 24th. Wall Street Zen lowered shares of Integer from a “buy” rating to a “hold” rating in a research note on Sunday, January 25th. Finally, KeyCorp cut their target price on shares of Integer from $145.00 to $133.00 and set an “overweight” rating for the company in a research report on Tuesday, October 21st. Four equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $98.38.

Integer Stock Performance

Shares of NYSE:ITGR opened at $85.03 on Friday. The company has a debt-to-equity ratio of 0.70, a current ratio of 3.71 and a quick ratio of 2.45. The business’s fifty day moving average price is $81.10 and its two-hundred day moving average price is $89.19. Integer Holdings Corporation has a fifty-two week low of $62.00 and a fifty-two week high of $144.76. The stock has a market capitalization of $2.98 billion, a price-to-earnings ratio of 35.58, a price-to-earnings-growth ratio of 0.80 and a beta of 0.77.

Integer declared that its board has approved a share buyback plan on Tuesday, November 4th that permits the company to repurchase $200.00 million in outstanding shares. This repurchase authorization permits the medical equipment provider to purchase up to 8.3% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s leadership believes its shares are undervalued.

Integer Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.